MedPath

Comparison of the effect of Olapatadine nasal spray with Mometasone spray in the treatment of allergic rhinosinusitis

Phase 3
Recruiting
Conditions
Allergic rhinosinusitis.
Allergic rhinosinusitis
Registration Number
IRCT20200727048222N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Age 18 to 60 years
Patients with confirmed allergic rhinosinusitis
Written consent to enter the study
Patient cooperation during the study
Timely and correct use of medication by asking the patient
Absence of abnormal nasal anatomy
Absence of severe nasal congestion due to polyps, other lesions and obstructive masses
Absence of respiratory infections
Non-smokers
Absence of upper and lower lung diseases affecting the final consumption or absorption of the nose
Absence of symptoms of systemic diseases

Exclusion Criteria

People known for not responding to antihistamines
Known intolerance or sensitivity to drugs

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.